Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Erwinia amylovora
Shift within age-groups of mumps incidence, hospitalizations and severe complications in a highly vaccinated population. Spain, 1998-2014.
Preserved priming across study-test picture transformations in patients with Alzheimer's disease.
Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1-3 clinical trials: a Children's Cancer and Leukaemia Group (CCLG) Study.
Daytime sleepiness, agonist therapy, and driving in Parkinson disease.
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Daytime sleepiness, agonist therapy, and driving in Parkinson disease.
Daytime sleepiness, agonist therapy, and driving in Parkinson disease. JAMA. 2002 Jan 23-30; 287(4):509-11.
View in:
PubMed
subject areas
Antiparkinson Agents
Automobile Driving
Disorders of Excessive Somnolence
Dopamine Agonists
Humans
Parkinson Disease
Risk